BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

829 related articles for article (PubMed ID: 15331738)

  • 1. A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV.
    Huang Z; Elankumaran S; Yunus AS; Samal SK
    J Virol; 2004 Sep; 78(18):10054-63. PubMed ID: 15331738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant infectious bursal disease virus expressing Newcastle disease virus (NDV) neutralizing epitope confers partial protection against virulent NDV challenge in chickens.
    Li K; Gao L; Gao H; Qi X; Gao Y; Qin L; Wang Y; Wang X
    Antiviral Res; 2014 Jan; 101():1-11. PubMed ID: 24200519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel in-ovo chimeric recombinant Newcastle disease vaccine protects against both Newcastle disease and infectious bursal disease.
    Ge J; Wang X; Tian M; Wen Z; Feng Q; Qi X; Gao H; Wang X; Bu Z
    Vaccine; 2014 Mar; 32(13):1514-21. PubMed ID: 24486349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against infectious bursal disease virulent challenge conferred by a recombinant avian adeno-associated virus vaccine.
    Perozo F; Villegas P; Estevez C; Alvarado IR; Purvis LB; Williams S
    Avian Dis; 2008 Jun; 52(2):315-9. PubMed ID: 18646463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpesvirus of turkey recombinant viruses expressing infectious bursal disease virus (IBDV) VP2 immunogen induce protection against an IBDV virulent challenge in chickens.
    Darteil R; Bublot M; Laplace E; Bouquet JF; Audonnet JC; Rivière M
    Virology; 1995 Aug; 211(2):481-90. PubMed ID: 7645252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of chickens against very virulent infectious bursal disease virus (IBDV) and Marek's disease virus (MDV) with a recombinant MDV expressing IBDV VP2.
    Tsukamoto K; Kojima C; Komori Y; Tanimura N; Mase M; Yamaguchi S
    Virology; 1999 May; 257(2):352-62. PubMed ID: 10329546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of two strains of Marek's disease virus serotype 1 for the development of recombinant vaccines against very virulent infectious bursal disease virus.
    Li K; Liu Y; Liu C; Gao L; Gao Y; Zhang Y; Cui H; Qi X; Zhong L; Wang X
    Antiviral Res; 2017 Mar; 139():153-160. PubMed ID: 27908832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete, long-lasting protection against lethal infectious bursal disease virus challenge by a single vaccination with an avian herpesvirus vector expressing VP2 antigens.
    Tsukamoto K; Saito S; Saeki S; Sato T; Tanimura N; Isobe T; Mase M; Imada T; Yuasa N; Yamaguchi S
    J Virol; 2002 Jun; 76(11):5637-45. PubMed ID: 11991992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of a turkey herpesvirus double construct vaccine (HVT-ND-IBD) against challenge with different strains of Newcastle disease, infectious bursal disease and Marek's disease viruses.
    van Hulten MCW; Cruz-Coy J; Gergen L; Pouwels H; Ten Dam GB; Verstegen I; de Groof A; Morsey M; Tarpey I
    Avian Pathol; 2021 Feb; 50(1):18-30. PubMed ID: 33063529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of recombinant VP2 vaccine for the prevention of infectious bursal disease of chickens.
    Rong J; Cheng T; Liu X; Jiang T; Gu H; Zou G
    Vaccine; 2005 Sep; 23(40):4844-51. PubMed ID: 15979770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular determinants of virulence, cell tropism, and pathogenic phenotype of infectious bursal disease virus.
    Brandt M; Yao K; Liu M; Heckert RA; Vakharia VN
    J Virol; 2001 Dec; 75(24):11974-82. PubMed ID: 11711587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective efficacy of a novel recombinant Marek's disease virus vector vaccine against infectious bursal disease in chickens with or without maternal antibodies.
    Li K; Liu Y; Zhang Y; Gao L; Liu C; Cui H; Qi X; Gao Y; Zhong L; Wang X
    Vet Immunol Immunopathol; 2017 Apr; 186():55-59. PubMed ID: 28413051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of chickens, with or without maternal antibodies, against IBDV infection by a recombinant IBDV-VP2 protein.
    Zhou X; Wang D; Xiong J; Zhang P; Li Y; She R
    Vaccine; 2010 May; 28(23):3990-6. PubMed ID: 20338216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimaeric VP2 proteins from infectious bursal disease virus containing the N-terminal M2e of H9 subtype avian influenza virus induce neutralizing antibody responses to both viruses.
    Tang Y; Gong Y; Wang Y; Wu P; Liu Y; Lu J; Gao F; Chen T; Hou F; Hou J
    Avian Pathol; 2013; 42(3):260-7. PubMed ID: 23607544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baculovirus virions displaying infectious bursal disease virus VP2 protein protect chickens against infectious bursal disease virus infection.
    Xu XG; Tong DW; Wang ZS; Zhang Q; Li ZC; Zhang K; Li W; Liu HJ
    Avian Dis; 2011 Jun; 55(2):223-9. PubMed ID: 21793437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infectious Bursal Disease Virus: Molecular Epidemiologic Perspectives and Impact on Vaccine Efficacy Against Avian Influenza and Newcastle Disease Viruses.
    El-Aried TA; Mansour SMG; ElBakrey RM; N Ismail AE; Eid AAM
    Avian Dis; 2019 Dec; 63(4):606-618. PubMed ID: 31865675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant Marek's disease virus type 1 provides full protection against very virulent Marek's and infectious bursal disease viruses in chickens.
    Li K; Liu Y; Liu C; Gao L; Zhang Y; Cui H; Gao Y; Qi X; Zhong L; Wang X
    Sci Rep; 2016 Dec; 6():39263. PubMed ID: 27982090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potent adjuvant effects of chicken beta-defensin-1 when genetically fused with infectious bursal disease virus VP2 gene.
    Zhang HH; Yang XM; Xie QM; Ma JY; Luo YN; Cao YC; Chen F; Bi YZ
    Vet Immunol Immunopathol; 2010 Jul; 136(1-2):92-7. PubMed ID: 20334934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of different promoters on the protective efficacy of recombinant Marek's disease virus type 1 expressing the VP2 gene of infectious bursal disease virus.
    Li K; Liu Y; Liu C; Gao L; Zhang Y; Gao Y; Cui H; Qi X; Zhong L; Wang X
    Vaccine; 2016 Nov; 34(47):5744-5750. PubMed ID: 27742216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Avian adenovirus CELO recombinants expressing VP2 of infectious bursal disease virus induce protection against bursal disease in chickens.
    Francois A; Chevalier C; Delmas B; Eterradossi N; Toquin D; Rivallan G; Langlois P
    Vaccine; 2004 Jun; 22(17-18):2351-60. PubMed ID: 15149796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.